The global Monoclonal Antibody ADC Drugs market was valued at US$ 617.6 million in 2023 and is anticipated to reach US$ 1831.6 million by 2030, witnessing a CAGR of 16.8% during the forecast period 2024-2030.

Monoclonal Antibody ADC Drugs Market

Monoclonal antibody ADC drug is a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies, and a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibody ADC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibody ADC Drugs.

Report Scope

The Monoclonal Antibody ADC Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Monoclonal Antibody ADC Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Monoclonal Antibody ADC Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Monoclonal Antibody ADC Drugs Market Report

Report Metric	Details
Report Name	Monoclonal Antibody ADC Drugs Market
Accounted market size in 2023	US$ 617.6 million
Forecasted market size in 2030	US$ 1831.6 million
CAGR	16.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	CD30 Target Antigen HER2 Target Antigen CD22 Target Antigen CD33 Target Antigen Nectin-4 Target Antigen Others
Segment by Application	Lymphoma Breast Cancer Leukemia Myeloma Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Seattle, Roche, Pfizer, AstraZeneca, Immunomedics, GSK, ADC Therapeutics, Lepu Biopharma, Shanghai Junshi Biosciences, RemeGen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoclonal Antibody ADC Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoclonal Antibody ADC Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Monoclonal Antibody ADC Drugs Market growing?

Ans: The Monoclonal Antibody ADC Drugs Market witnessing a CAGR of 16.8% during the forecast period 2024-2030.

What is the Monoclonal Antibody ADC Drugs Market size in 2030?

Ans: The Monoclonal Antibody ADC Drugs Market size in 2030 will be US$ 1831.6 million.

Who are the main players in the Monoclonal Antibody ADC Drugs Market report?

Ans: The main players in the Monoclonal Antibody ADC Drugs Market are Seattle, Roche, Pfizer, AstraZeneca, Immunomedics, GSK, ADC Therapeutics, Lepu Biopharma, Shanghai Junshi Biosciences, RemeGen

What are the Application segmentation covered in the Monoclonal Antibody ADC Drugs Market report?

Ans: The Applications covered in the Monoclonal Antibody ADC Drugs Market report are Lymphoma, Breast Cancer, Leukemia, Myeloma, Others

What are the Type segmentation covered in the Monoclonal Antibody ADC Drugs Market report?

Ans: The Types covered in the Monoclonal Antibody ADC Drugs Market report are CD30 Target Antigen, HER2 Target Antigen, CD22 Target Antigen, CD33 Target Antigen, Nectin-4 Target Antigen, Others

1 Monoclonal Antibody ADC Drugs Market Overview

1.1 Product Overview and Scope of Monoclonal Antibody ADC Drugs

1.2 Monoclonal Antibody ADC Drugs Segment by Type

1.2.1 Global Monoclonal Antibody ADC Drugs Market Value Comparison by Type (2024-2030)

1.2.2 CD30 Target Antigen

1.2.3 HER2 Target Antigen

1.2.4 CD22 Target Antigen

1.2.5 CD33 Target Antigen

1.2.6 Nectin-4 Target Antigen

1.2.7 Others

1.3 Monoclonal Antibody ADC Drugs Segment by Application

1.3.1 Global Monoclonal Antibody ADC Drugs Market Value by Application: (2024-2030)

1.3.2 Lymphoma

1.3.3 Breast Cancer

1.3.4 Leukemia

1.3.5 Myeloma

1.3.6 Others

1.4 Global Monoclonal Antibody ADC Drugs Market Size Estimates and Forecasts

1.4.1 Global Monoclonal Antibody ADC Drugs Revenue 2019-2030

1.4.2 Global Monoclonal Antibody ADC Drugs Sales 2019-2030

1.4.3 Global Monoclonal Antibody ADC Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Monoclonal Antibody ADC Drugs Market Competition by Manufacturers

2.1 Global Monoclonal Antibody ADC Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Monoclonal Antibody ADC Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Monoclonal Antibody ADC Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Product Type & Application

2.7 Monoclonal Antibody ADC Drugs Market Competitive Situation and Trends

2.7.1 Monoclonal Antibody ADC Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Monoclonal Antibody ADC Drugs Players Market Share by Revenue

2.7.3 Global Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Monoclonal Antibody ADC Drugs Retrospective Market Scenario by Region

3.1 Global Monoclonal Antibody ADC Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Monoclonal Antibody ADC Drugs Global Monoclonal Antibody ADC Drugs Sales by Region: 2019-2030

3.2.1 Global Monoclonal Antibody ADC Drugs Sales by Region: 2019-2024

3.2.2 Global Monoclonal Antibody ADC Drugs Sales by Region: 2025-2030

3.3 Global Monoclonal Antibody ADC Drugs Global Monoclonal Antibody ADC Drugs Revenue by Region: 2019-2030

3.3.1 Global Monoclonal Antibody ADC Drugs Revenue by Region: 2019-2024

3.3.2 Global Monoclonal Antibody ADC Drugs Revenue by Region: 2025-2030

3.4 North America Monoclonal Antibody ADC Drugs Market Facts & Figures by Country

3.4.1 North America Monoclonal Antibody ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Monoclonal Antibody ADC Drugs Sales by Country (2019-2030)

3.4.3 North America Monoclonal Antibody ADC Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Monoclonal Antibody ADC Drugs Market Facts & Figures by Country

3.5.1 Europe Monoclonal Antibody ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Monoclonal Antibody ADC Drugs Sales by Country (2019-2030)

3.5.3 Europe Monoclonal Antibody ADC Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Monoclonal Antibody ADC Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Monoclonal Antibody ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Monoclonal Antibody ADC Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Monoclonal Antibody ADC Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Monoclonal Antibody ADC Drugs Market Facts & Figures by Country

3.7.1 Latin America Monoclonal Antibody ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Monoclonal Antibody ADC Drugs Sales by Country (2019-2030)

3.7.3 Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Monoclonal Antibody ADC Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Monoclonal Antibody ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Monoclonal Antibody ADC Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Monoclonal Antibody ADC Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Monoclonal Antibody ADC Drugs Sales by Type (2019-2030)

4.1.1 Global Monoclonal Antibody ADC Drugs Sales by Type (2019-2024)

4.1.2 Global Monoclonal Antibody ADC Drugs Sales by Type (2025-2030)

4.1.3 Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2019-2030)

4.2 Global Monoclonal Antibody ADC Drugs Revenue by Type (2019-2030)

4.2.1 Global Monoclonal Antibody ADC Drugs Revenue by Type (2019-2024)

4.2.2 Global Monoclonal Antibody ADC Drugs Revenue by Type (2025-2030)

4.2.3 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Monoclonal Antibody ADC Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Monoclonal Antibody ADC Drugs Sales by Application (2019-2030)

5.1.1 Global Monoclonal Antibody ADC Drugs Sales by Application (2019-2024)

5.1.2 Global Monoclonal Antibody ADC Drugs Sales by Application (2025-2030)

5.1.3 Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2019-2030)

5.2 Global Monoclonal Antibody ADC Drugs Revenue by Application (2019-2030)

5.2.1 Global Monoclonal Antibody ADC Drugs Revenue by Application (2019-2024)

5.2.2 Global Monoclonal Antibody ADC Drugs Revenue by Application (2025-2030)

5.2.3 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Monoclonal Antibody ADC Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Seattle

6.1.1 Seattle Corporation Information

6.1.2 Seattle Description and Business Overview

6.1.3 Seattle Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Seattle Monoclonal Antibody ADC Drugs Product Portfolio

6.1.5 Seattle Recent Developments/Updates

6.2 Roche

6.2.1 Roche Corporation Information

6.2.2 Roche Description and Business Overview

6.2.3 Roche Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Roche Monoclonal Antibody ADC Drugs Product Portfolio

6.2.5 Roche Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Pfizer Monoclonal Antibody ADC Drugs Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 AstraZeneca

6.4.1 AstraZeneca Corporation Information

6.4.2 AstraZeneca Description and Business Overview

6.4.3 AstraZeneca Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 AstraZeneca Monoclonal Antibody ADC Drugs Product Portfolio

6.4.5 AstraZeneca Recent Developments/Updates

6.5 Immunomedics

6.5.1 Immunomedics Corporation Information

6.5.2 Immunomedics Description and Business Overview

6.5.3 Immunomedics Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Immunomedics Monoclonal Antibody ADC Drugs Product Portfolio

6.5.5 Immunomedics Recent Developments/Updates

6.6 GSK

6.6.1 GSK Corporation Information

6.6.2 GSK Description and Business Overview

6.6.3 GSK Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 GSK Monoclonal Antibody ADC Drugs Product Portfolio

6.6.5 GSK Recent Developments/Updates

6.7 ADC Therapeutics

6.6.1 ADC Therapeutics Corporation Information

6.6.2 ADC Therapeutics Description and Business Overview

6.6.3 ADC Therapeutics Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Portfolio

6.7.5 ADC Therapeutics Recent Developments/Updates

6.8 Lepu Biopharma

6.8.1 Lepu Biopharma Corporation Information

6.8.2 Lepu Biopharma Description and Business Overview

6.8.3 Lepu Biopharma Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Lepu Biopharma Monoclonal Antibody ADC Drugs Product Portfolio

6.8.5 Lepu Biopharma Recent Developments/Updates

6.9 Shanghai Junshi Biosciences

6.9.1 Shanghai Junshi Biosciences Corporation Information

6.9.2 Shanghai Junshi Biosciences Description and Business Overview

6.9.3 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Portfolio

6.9.5 Shanghai Junshi Biosciences Recent Developments/Updates

6.10 RemeGen

6.10.1 RemeGen Corporation Information

6.10.2 RemeGen Description and Business Overview

6.10.3 RemeGen Monoclonal Antibody ADC Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 RemeGen Monoclonal Antibody ADC Drugs Product Portfolio

6.10.5 RemeGen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Monoclonal Antibody ADC Drugs Industry Chain Analysis

7.2 Monoclonal Antibody ADC Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Monoclonal Antibody ADC Drugs Production Mode & Process

7.4 Monoclonal Antibody ADC Drugs Sales and Marketing

7.4.1 Monoclonal Antibody ADC Drugs Sales Channels

7.4.2 Monoclonal Antibody ADC Drugs Distributors

7.5 Monoclonal Antibody ADC Drugs Customers

8 Monoclonal Antibody ADC Drugs Market Dynamics

8.1 Monoclonal Antibody ADC Drugs Industry Trends

8.2 Monoclonal Antibody ADC Drugs Market Drivers

8.3 Monoclonal Antibody ADC Drugs Market Challenges

8.4 Monoclonal Antibody ADC Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shanghai Junshi Biosciences

RemeGen, Ltd.

Astrazeneca plc

List of Tables

Table 1. Global Monoclonal Antibody ADC Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Monoclonal Antibody ADC Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Monoclonal Antibody ADC Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Monoclonal Antibody ADC Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Monoclonal Antibody ADC Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Monoclonal Antibody ADC Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Monoclonal Antibody ADC Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Monoclonal Antibody ADC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody ADC Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Monoclonal Antibody ADC Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Monoclonal Antibody ADC Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Monoclonal Antibody ADC Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Monoclonal Antibody ADC Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Monoclonal Antibody ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Monoclonal Antibody ADC Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Monoclonal Antibody ADC Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Monoclonal Antibody ADC Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Monoclonal Antibody ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Monoclonal Antibody ADC Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Monoclonal Antibody ADC Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Monoclonal Antibody ADC Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Monoclonal Antibody ADC Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Monoclonal Antibody ADC Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Monoclonal Antibody ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Monoclonal Antibody ADC Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Monoclonal Antibody ADC Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Monoclonal Antibody ADC Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Monoclonal Antibody ADC Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Seattle Corporation Information

Table 71. Seattle Description and Business Overview

Table 72. Seattle Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Seattle Monoclonal Antibody ADC Drugs Product

Table 74. Seattle Recent Developments/Updates

Table 75. Roche Corporation Information

Table 76. Roche Description and Business Overview

Table 77. Roche Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Roche Monoclonal Antibody ADC Drugs Product

Table 79. Roche Recent Developments/Updates

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Pfizer Monoclonal Antibody ADC Drugs Product

Table 84. Pfizer Recent Developments/Updates

Table 85. AstraZeneca Corporation Information

Table 86. AstraZeneca Description and Business Overview

Table 87. AstraZeneca Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. AstraZeneca Monoclonal Antibody ADC Drugs Product

Table 89. AstraZeneca Recent Developments/Updates

Table 90. Immunomedics Corporation Information

Table 91. Immunomedics Description and Business Overview

Table 92. Immunomedics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Immunomedics Monoclonal Antibody ADC Drugs Product

Table 94. Immunomedics Recent Developments/Updates

Table 95. GSK Corporation Information

Table 96. GSK Description and Business Overview

Table 97. GSK Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. GSK Monoclonal Antibody ADC Drugs Product

Table 99. GSK Recent Developments/Updates

Table 100. ADC Therapeutics Corporation Information

Table 101. ADC Therapeutics Description and Business Overview

Table 102. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. ADC Therapeutics Monoclonal Antibody ADC Drugs Product

Table 104. ADC Therapeutics Recent Developments/Updates

Table 105. Lepu Biopharma Corporation Information

Table 106. Lepu Biopharma Description and Business Overview

Table 107. Lepu Biopharma Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Lepu Biopharma Monoclonal Antibody ADC Drugs Product

Table 109. Lepu Biopharma Recent Developments/Updates

Table 110. Shanghai Junshi Biosciences Corporation Information

Table 111. Shanghai Junshi Biosciences Description and Business Overview

Table 112. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product

Table 114. Shanghai Junshi Biosciences Recent Developments/Updates

Table 115. RemeGen Corporation Information

Table 116. RemeGen Description and Business Overview

Table 117. RemeGen Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. RemeGen Monoclonal Antibody ADC Drugs Product

Table 119. RemeGen Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Monoclonal Antibody ADC Drugs Distributors List

Table 123. Monoclonal Antibody ADC Drugs Customers List

Table 124. Monoclonal Antibody ADC Drugs Market Trends

Table 125. Monoclonal Antibody ADC Drugs Market Drivers

Table 126. Monoclonal Antibody ADC Drugs Market Challenges

Table 127. Monoclonal Antibody ADC Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Monoclonal Antibody ADC Drugs

Figure 2. Global Monoclonal Antibody ADC Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Monoclonal Antibody ADC Drugs Market Share by Type in 2023 & 2030

Figure 4. CD30 Target Antigen Product Picture

Figure 5. HER2 Target Antigen Product Picture

Figure 6. CD22 Target Antigen Product Picture

Figure 7. CD33 Target Antigen Product Picture

Figure 8. Nectin-4 Target Antigen Product Picture

Figure 9. Others Product Picture

Figure 10. Global Monoclonal Antibody ADC Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Monoclonal Antibody ADC Drugs Market Share by Application in 2023 & 2030

Figure 12. Lymphoma

Figure 13. Breast Cancer

Figure 14. Leukemia

Figure 15. Myeloma

Figure 16. Others

Figure 17. Global Monoclonal Antibody ADC Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Monoclonal Antibody ADC Drugs Market Size (2019-2030) & (US$ Million)

Figure 19. Global Monoclonal Antibody ADC Drugs Sales (2019-2030) & (K Units)

Figure 20. Global Monoclonal Antibody ADC Drugs Average Price (US$/Unit) & (2019-2030)

Figure 21. Monoclonal Antibody ADC Drugs Report Years Considered

Figure 22. Monoclonal Antibody ADC Drugs Sales Share by Manufacturers in 2023

Figure 23. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers in 2023

Figure 24. The Global 5 and 10 Largest Monoclonal Antibody ADC Drugs Players: Market Share by Revenue in 2023

Figure 25. Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 26. Global Monoclonal Antibody ADC Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 27. North America Monoclonal Antibody ADC Drugs Sales Market Share by Country (2019-2030)

Figure 28. North America Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2019-2030)

Figure 29. United States Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Canada Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Country (2019-2030)

Figure 32. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2019-2030)

Figure 33. Germany Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. France Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. U.K. Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Italy Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Russia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Monoclonal Antibody ADC Drugs Sales Market Share by Region (2019-2030)

Figure 39. Asia Pacific Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2019-2030)

Figure 40. China Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Japan Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. South Korea Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. India Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Australia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. China Taiwan Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Monoclonal Antibody ADC Drugs Sales Market Share by Country (2019-2030)

Figure 48. Latin America Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Monoclonal Antibody ADC Drugs Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Monoclonal Antibody ADC Drugs Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Monoclonal Antibody ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Monoclonal Antibody ADC Drugs by Type (2019-2030)

Figure 58. Global Revenue Market Share of Monoclonal Antibody ADC Drugs by Type (2019-2030)

Figure 59. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Monoclonal Antibody ADC Drugs by Application (2019-2030)

Figure 61. Global Revenue Market Share of Monoclonal Antibody ADC Drugs by Application (2019-2030)

Figure 62. Global Monoclonal Antibody ADC Drugs Price (US$/Unit) by Application (2019-2030)

Figure 63. Monoclonal Antibody ADC Drugs Value Chain

Figure 64. Monoclonal Antibody ADC Drugs Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions